We are live on ! Find out more
BSX icon

Boston Scientific

1,643 hedge funds and large institutions have $135B invested in Boston Scientific in 2025 Q1 according to their latest regulatory filings, with 230 funds opening new positions, 667 increasing their positions, 553 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more first-time investments, than exits

New positions opened: 230 | Existing positions closed: 73

31% more call options, than puts

Call options by funds: $1.07B | Put options by funds: $819M

31% more funds holding in top 10

Funds holding in top 10: 3951 (+12)

21% more repeat investments, than reductions

Existing positions increased: 667 | Existing positions reduced: 553

12% more capital invested

Capital invested by funds: $120B → $135B (+$14.8B)

9% more funds holding

Funds holding: 1,5131,643 (+130)

0.19% less ownership

Funds ownership: 90.98%90.79% (-0.19%)

Holders
1,643
Holders Change
+130
Holders Change %
+8.59%
% of All Funds
22.03%
Holding in Top 10
51
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+30.77%
% of All Funds
0.68%
New
230
Increased
667
Reduced
553
Closed
73
Calls
$1.07B
Puts
$819M
Net Calls
+$256M
Net Calls Change
+$371M
Name Holding Trade Value Shares
Change
Change in
Stake
JCM
301
Jag Capital Management
Missouri
$21.8M +$4.63M +45,983 +27%
PFSRSONJ
302
Police & Firemen's Retirement System of New Jersey
New Jersey
$21.6M
ADEF
303
Adams Diversified Equity Fund
Maryland
$21.6M
Mirae Asset Global Investments
304
Mirae Asset Global Investments
South Korea
$21.5M +$3.46M +34,404 +19%
IG
305
ING Group
Netherlands
$21.3M +$2.29M +22,753 +12%
EB
306
Eastern Bank
Massachusetts
$21.1M -$9.64M -95,688 -31%
SMFG
307
Sumitomo Mitsui Financial Group
Japan
$20.7M +$5.52M +54,832 +36%
B
308
Bailard
California
$20.7M +$125K +1,237 +0.6%
NYLIM
309
New York Life Investment Management
New York
$20.4M -$124K -1,227 -0.6%
AIM
310
Achmea Investment Management
Netherlands
$20.2M +$6.01M +59,682 +43%
CM
311
Churchill Management
California
$19.8M -$56.3K -559 -0.3%
MWM
312
Moran Wealth Management
Florida
$19.8M -$327K -3,250 -2%
HF
313
HRT Financial
New York
$19.6M +$19.6M +194,779 New
SMDAM
314
Sumitomo Mitsui DS Asset Management
Japan
$19.6M +$690K +6,855 +4%
RG
315
Redmile Group
California
$19.5M -$12M -119,400 -38%
SIC
316
Salem Investment Counselors
North Carolina
$19.5M -$397K -3,944 -2%
PI
317
PGGM Investments
Netherlands
$19.4M
PD
318
Point72 (DIFC)
United Arab Emirates
$19.2M +$17.5M +173,529 +1,056%
OAM
319
OP Asset Management
$18.9M +$18.9M +187,683 New
Corient Private Wealth
320
Corient Private Wealth
Florida
$18.9M +$1.72M +17,097 +10%
First Manhattan
321
First Manhattan
New York
$18.9M -$257K -2,551 -1%
KAS
322
Kestra Advisory Services
Texas
$18.9M -$2.96M -29,366 -14%
HIMC
323
Heritage Investors Management Corp
Maryland
$18.8M -$885K -8,792 -5%
Parallax Volatility Advisers
324
Parallax Volatility Advisers
California
$18.7M +$387K +3,840 +2%
NAM
325
Nissay Asset Management
Japan
$18.5M +$240K +2,380 +1%

BSX Hedge Fund Activity: Q1 2025 in Review

1,643 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2025, worth a combined $135B — up 12% from $120B a quarter earlier.

Buyers outnumbered sellers: 230 funds opened new BSX positions and 73 closed out — a net gain of 157 holders — while 667 added to existing stakes and 553 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $532M. The largest seller was Franklin Resources, cutting an estimated $915M.

  • 1,643 institutional investors held Boston Scientific (BSX) as of Q1 2025, up from 1,513 in Q4 2024.
  • Funds reported $135B of Boston Scientific stock for Q1 2025, up 12% quarter-over-quarter.
  • 230 funds opened new Boston Scientific positions in Q1 2025 and 73 closed out, a net change of +157 holders.
  • The largest Boston Scientific buyer in Q1 2025 was JP Morgan Chase, an estimated $532M added.
  • The largest Boston Scientific seller in Q1 2025 was Franklin Resources, an estimated $915M sold.

Based on aggregated 13F filings for Q1 2025.